Zamonaviy dunyoda innovatsion tadqiqotlar 2-jild vative-son (2023) · 32–33-betlar

EPIDEMIOLOGICAL FEATURES OF MACULAR EDEMA TREATMENT IN PATIENTS WITH DIABETES MELLITUS

Abdusalamova, Azizakhon

DOI: 10.5281/zenodo.7793745 · Manbada o'qish →

Annotatsiya

Diabetic macular edema (DME) is the most common cause of vision loss in both type 1 (T1) and type 2 (T2) diabetes mellitus (DM). The reported incidence of DME varies greatly from 0 to 3% in newly diagnosed cases to 28-29% in chronic diabetic patients with more than 20 years of disease duration. Similarly, the reported incidence of DMO ranges widely from 0.8 to 7.5% The pathogenesis of DMO is complex and poorly understood.

diabetic macular edema, diabetes mellitus, glycemic control

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex to'liq matnni saqlamaydi, manbaga havola beradi.